What are the ethical concerns of gene editing?

Gene editing raises ethical concerns because it alters biological instructions that affect individuals, families, communities, and ecosystems. The technology promises therapies for genetic disease but also creates choices about which traits are valued, who has access, and how harms are distributed. Debate among scientists, ethicists, and policymakers has emphasized both potential benefits and deep risks, prompting calls for governance and public engagement from leading institutions. Ethical Principles at Stake Core moral principles include safety, consent, justice, and respect for persons. Safety concerns center on unintended genetic changes and long-term effects. Jennifer Doudna at University of California, Berkeley and Emmanuelle Charpentier at Max Planck Unit for the Science of Pathogens have urged caution about altering the human germline because unintended consequences can be inherited by future generations. Consent is complex when edits affect future people who cannot agree, raising questions about surrogate decision making and the moral status of embryos. Justice concerns arise when access to gene editing is unequal, potentially widening health disparities between wealthy and marginalized communities. The National Academies of Sciences, Engineering, and Medicine has recommended frameworks that weigh potential benefits against risks while emphasizing equity in access and oversight. Social and Environmental Consequences Gene editing interacts with cultural values, social identity, and territory. Different communities may have distinct views on modifying particular traits, and imposing a dominant standard risks cultural harm. In agriculture, editing crops and wild species can change ecosystems; ecological effects may cross borders, affecting territories and Indigenous lands in unpredictable ways. The Nuffield Council on Bioethics has explored social implications of reproductive genome editing, noting that cultural norms shape decisions about which interventions are acceptable. Misuse is another ethical concern: dual-use risks include applications that harm rather than heal, prompting the World Health Organization to call for international governance and risk mitigation strategies. Accountability, transparency, and trust are central to ethical practice. The case of He Jiankui, whose germline edits prompted widespread condemnation, illustrated how clandestine research can erode public trust and lead to legal and professional consequences for individuals who bypass norms and oversight. Francis Collins at National Institutes of Health and other leaders emphasized the need for clear regulatory frameworks and global cooperation after that incident. Ethical governance therefore involves not only technical assessments but robust systems for oversight, reporting, and community engagement. Policy and Public Deliberation Ethical responses must combine scientific assessment, legal safeguards, and inclusive public deliberation. International bodies and national authorities have recommended staged governance that differentiates somatic therapies from inheritable germline changes, with stricter oversight for interventions that affect future generations. Public engagement should include affected communities, Indigenous peoples, and those in vulnerable regions to ensure that cultural and territorial implications are considered. Environmental monitoring and contingency planning can reduce ecological risks, while equitable funding and access policies can address justice concerns. Responsible stewardship of gene editing requires sustained interdisciplinary dialogue and institutional accountability to align technological possibilities with societal values.